Akorn recalls 150mg Rifampin capsules due to stability concerns after the manufacturer closed. All lots and NDCs are affected. No remedy provided in official notice.
CGMP Deviations: Firm went out of business and could no longer continue stability studies.
Akorn is recalling all 150mg Rifampin capsules because the manufacturer went out of business and can no longer ensure the product's stability. This means the medication may not be safe for use as intended.
The manufacturer went out of business and could no longer conduct stability studies. This means the product's safety and effectiveness cannot be confirmed after the closure. Without ongoing testing, there's a risk the medication may degrade or become unsafe.
Prescription holders of Akorn's Rifampin capsules are affected. Patients with this medication should contact their healthcare provider for guidance.
Check for Akorn Rifampin Capsules USP 150mg, 30-count bottles with Rx Only label. All lots and National Drug Codes (NDCs) are included in this recall.
Since the manufacturer closed and cannot ensure stability, patients should consult their doctor about alternative medications.
The manufacturer went out of business and can no longer conduct stability studies, making the product's safety uncertain.
Contact your healthcare provider for guidance on alternative medications since the manufacturer cannot ensure stability.
The official recall notice does not specify a deadline for action.
We’ve drafted a message you can send Akorn to request your refund or repair — edit it as you like.
Subject: Recall D-0840-2023 — Akorn Akorn Hello, I own a Akorn that is covered by recall D-0840-2023 from Akorn. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
